Exicure (XCUR) Change in Account Payables (2016 - 2026)
Exicure (XCUR) reported Change in Account Payables of $755000.0 for Q1 2026, up 276.81% on a YoY basis from $200363.6 in Q1 2025, and up 86.88% quarter-over-quarter from $404000.0 in Q4 2025.
Exicure (XCUR) Change in Account Payables (2016 - 2026) Analysis & Trends
Exicure has reported Change in Account Payables for 11 years, with the latest figure at $755000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 276.81% year-over-year to $755000.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 266.95% YoY), and the FY2025 full-year result was $177000.0, up 191.71% from the prior year.
- Change in Account Payables for Q1 2026 stood at $755000.0, up from $404000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $766000.0 in Q4 2023, with the low at -$1.5 million in Q1 2022.
- Historically, Change in Account Payables has averaged -$61352.9 across 5 years, with a median of -$109000.0 in 2023.
- Annual changes were most pronounced in 2022 — Change in Account Payables sank 414.49% — and 2025, when it surged 404.17%.
- Exicure's Change in Account Payables stood at -$559000.0 in 2022, then soared by 237.03% to $766000.0 in 2023, then plunged by 86.95% to $100000.0 in 2024, then soared by 304.0% to $404000.0 in 2025, then surged by 86.88% to $755000.0 in 2026.
- The last three Change in Account Payables figures came in at $755000.0 (Q1 2026), $404000.0 (Q4 2025), and -$530000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -9.42 Mn |
| 10 | Exicure | 18.48 Mn | 15.88 Mn | - | 755,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 755,000.00 |
| Mar 31, 2026 | 755,000.00 |
| Dec 31, 2025 | 404,000.00 |
| Dec 31, 2025 | 404,000.00 |
| Sep 30, 2025 | -530,000.00 |
| Sep 30, 2025 | -530,000.00 |
| Jun 30, 2025 | 730,000.00 |
| Jun 30, 2025 | 730,000.00 |
| Mar 31, 2025 | -427,000.00 |
| Mar 31, 2025 | -427,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | -247,000.00 |
| Sep 30, 2024 | -247,000.00 |
| Jun 30, 2024 | -240,000.00 |
| Jun 30, 2024 | -240,000.00 |
| Mar 31, 2024 | 194,000.00 |
| Mar 31, 2024 | 194,000.00 |
| Dec 31, 2023 | 766,000.00 |
| Dec 31, 2023 | 766,000.00 |